The Biliary Tree



The Biliary Tree





10.1 Cholecystitis and Biliary Colic

Am Fam Phys 2000;61:1673; Clin Perspect Gastro 2000;March:87

Epidem: The risk of gallstones rises with age. The prevalence of gallstones in young women is 5-8% and rises to 35% in women over age 75 yr. The prevalence in men rises to 20% by age 70 yr. Risk rises later for men, presumably because pregnancy confers earlier risk on women. Obesity is a strong risk for gallstones, especially in women, and 10-25% of pts develop stones with rapid weight loss (Ann IM 1993;119:1029). In younger age groups, the M:F ratio is 2:1. Estrogen replacement rx increases risk (GE 1988;94:91). Increased levels of estrogens promote biliary cholesterol supersaturation and may account for some of the observed difference. The incidence of gallstones in pregnant pts is 2%, though sludge develops in 30% and disappears postpartum in half of these pts (Ann IM 1993;119:116). Recreational physical activity reduces risk (independent of weight). Magnesium may be protective (Am J Gastro 2008;103:375).

Hypertriglyceridemia increases HMG-CoA reductase activity and thereby increases risk by promoting cholesterol secretion into bile (Semin Liver Dis 1990;10:159). Certain ethnic groups (eg, Pima Indian women of the southwestern U.S., native Chileans) have a very high incidence. Blacks have a lower risk than whites. Spinal cord injury causes gallbladder hypomotility and changes in biliary lipids that promote stone formation (GE 1987;92:966).

Pathophys: In the U.S., 85% of stones are composed of cholesterol. Pigment stones (composed largely of calcium bilirubinate) and mixed stones represent the remainder. The pathophysiology of pigment stone formation is notunderstood, but the physical-chemical basis of cholesterol gallstone formation has been extensively studied. There are 3 lipid species in bile: (1) cholesterol (4%), (2) phospholipids (22%, mainly as phosphatidylcholine, aka lecithin), and (3) bile salts (67%) (Semin Liver Dis 1990;10:159). Small amounts of bilirubin (0.3%) and protein (4.5%) are also present. Cholesterol is notwater soluble (it is hydrophobic). Bile salts and lecithins have polar and nonpolar surfaces and are called “amphiphiles.” The polar surfaces allow the bile salts to dissolve in water. The biliary cholesterol is carried in stable particles (micelles) made up of lecithin and bile salts.

Bile is supersaturated when the capacity of the bile salts and lecithin to keep cholesterol in solution is exceeded. Supersaturation is the first step in stone formation and
generally occurs because of excess cholesterol secretion into bile. Nucleation is the initial transition from liquid cholesterol crystals to solid cholesterol crystals in bile. While many people have supersaturated bile, stones precipitate in only a small number. The most important nucleating factor is gallbladder mucin, but other pronucleating and antinucleating proteins have been identified. Gallbladder stasis promotes stone formation by allowing stones to grow without being expelled from the gallbladder.



  • Biliary sludge: Sludge is a mixture of gallbladder mucin and small cholesterol or calcium bilirubinate crystals from which macroscopic stones can develop (GE 1988;95:508). Sludge can be detected by US and can cause biliary sx such as colic, cholecystitis, or pancreatitis. Pts with asymptomatic sludge can be managed expectantly. Pts who have rapid weight loss, take ceftriaxone, take octreotide, are pregnant, or have undergone organ transplantation are at risk for sludge (Ann IM 1999;130:301).


  • Consequences of stone development: Pts with gallstones may (1) remain asymptomatic; (2) develop biliary colic from intermittent, brief cystic duct obstruction; (3) develop acute cholecystitis from prolonged cystic duct obstruction, with secondary inflammation and bacterial infection; (4) develop chronic cholecystitis from recurrent acute bouts; (5) experience migration of stones into the common bile duct and into the duodenum that may cause pain, pancreatitis, or cholangitis; (6) develop gallbladder cancer; or (7) develop gallstone ileus (bowel obstruction by a gallstone).


  • Acalculous cholecystitis: This condition is cholecystitis in the absence of stones. It is most often seen in pts as a complication of major surgery, trauma, or burns. The precise mechanisms are unknown (J Am Coll Surg 1995;180:232).


  • Xanthogranulomatous cholecystitis: This abnormality is found in about 1.7% of excised gallbladders. It is a destructive, fibrosing, inflammatory condition of the gallbladder characterized by the presence of lipid-laden macrophages, which possibly develop in response to extravasated bile (J Clin Pathol 1987;40:412).

Sx:



  • Biliary colic: Most gallstones do notcause sx. The most common sx associated with gallstones is referred to as biliary colic (Postgrad Med 1991;90:119). The hallmark of biliary colic is discrete, unpredictable attacks of pain, lasting minutes to 5 hr before subsiding. The frequency of attacks is greater at night. The pt feels well between attacks. The pain is generally epigastric or RUQ (and occasionally substernal or LUQ). The pain often radiates outside the abdomen, typically to below the scapula. Nausea and vomiting may occur. Fever is uncommon without cholecystitis. Contrary to common teaching, there is no evidence that fatty food intolerance, belching, or bloating are related to the development of gallstones (Scand J Gastroenterol 2000;35:70). For sx that occur predictably or very frequently (> once weekly), a cause other than gallstones should be considered.


  • Acute cholecystitis: In this complication, the pt begins with an attack of biliary colic that fails to resolve. The pain tends to localize to the RUQ and may be associated with vomiting. Fever may develop. An important minority of pts may have little if any pain, especially diabetics, the immunocompromised, pts with CNS disease, and pts on steroids.


  • Acute pancreatitis: Gallstones may first present with sx of AP (p 187).


  • Choledocholithiasis: These pts may present with sx of biliary colic (frequently with radiation to the scapula), jaundice, dark urine, or pancreatitis, or they may be asymptomatic.



  • Cholangitis: Classically these pts present with Charcot’s triad: fever, RUQ pain, and jaundice. All of these findings might notnecessarily be present.

Si: In biliary colic, there are usually no physical findings. In cholecystitis, localized tenderness with peritoneal findings (percussion tenderness, guarding, or rebound) may develop. Many pts will demonstrate Murphy’s sign, the abrupt cessation of inspiration because of worsening of the pain when examiner is palpating the RUQ. A RUQ mass may be palpable. Pts with cholangitis typically have jaundice and fever but are notuniversally tender in the RUQ.

Crs: (Ann IM 1993;119:606) Most gallstones remain asymptomatic. In the group of pts who initially are asymptomatic with their stones, sx will later develop at a rate of 1-2%/yr. The rate may be higher (4%/yr) in the first 5 yr. Once pts develop an attack of biliary colic, the chance of recurrent attacks is high, but 30% of pts will nothave a second attack within 10 yr of follow-up. The rate of AP may be higher in pts with small stones (Arch IM 1997;157:1674).

Cmplc: Gallbladder cancer (p 208). A few pts will develop a stone that is impacted in the gallbladder neck and obstructs the common duct. This is referred to as Mirizzi’s syndrome (Am Surg 1994;60:889). Cholecystocholedochal fistula and gallstone ileus (obstruction of the small bowel by a stone passed through a fistula) are uncommon (BMJ 2002;325:639).

Diff Dx: Depending on the presentation, the differential is that of dyspepsia (p 2), pancreatitis (p 187), or jaundice (p 29).

Lab: Labs are normal in biliary colic. LFTs, amylase, and lipase should be obtained in the evaluation of attacks of suspected biliary pain in order to look for evidence of pancreatitis or common duct stones. In the acute passage of stones, the transaminases can be very high (200-800 U/L) and may have a pattern more suggestive of hepatitis than obstruction. If the stone passes, the LFTs rapidly normalize. If obstruction persists, the alk phos and bilirubin slowly climb and transaminases stay 2-3 times normal. A leukocytosis may be seen in cholecystitis.

X-ray:



  • Biliary colic: US is the test of choice for pts with suspected biliary colic. A typically quoted sensitivity is 97%, with specificity at 99%. However, since many pts with negative US never have the gold standard test (cholecystectomy), adjusted sensitivities of 90% for sensitivity and 97% for specificity have been proposed (Arch IM 1994;154:2573). CT is insensitive and nota reliable negative. In oral cholecystogram (OCG), pts swallow giant tablets of a contrast agent. The contrast agent is excreted in bile and taken up in the gallbladder. OCG is notoften used because it is less sensitive than US and because it is nonspecific if nonvisualization of the gallbladder is taken as a positive.


  • Acute cholecystitis: US is usually the test done first to look for gallstones in this setting. US may reveal direct evidence of cholecystitis, such as a thickened gallbladder wall or surrounding fluid collection. US may show evidence of dilated bile ducts from choledocholithiasis. If US is negative and acute cholecystitis is suspected, a radionuclide scan (typically called a HIDA scan no matter what isotope is used) is performed.

    In normal pts, the radiolabel is excreted into bile and flows into the gallbladder. If the cystic duct is obstructed (as in acute cholecystitis), the tracer is notvisualized in the gallbladder and the test is positive. The sensitivity is 97% and the specificity is 90%. Since cholecystitis may occur without stones, HIDA scanning has advantages over US in the dx of acalculous cholecystitis.



  • Common duct stones: CT and US are poor tests for common duct stones. ERCP is the test of choice for pts with a high clinical suspicion of common duct stones (bilirubin >4 mg/dl, cholangitis, or dilated CBD on US with bilirubin 1.8-4 mg/dl) because of the potential for endoscopic rx. If the pt is undergoing surgery, then an intraoperative cholangiogram is a cost-effective alternative when suspicion is intermediate. Preoperative EUS or MRCP are alternatives when suspicion is intermediate (Gastro Endosc 2010;71:1).

Rx:



  • Laparoscopic cholecystectomy (lap chole): Pts with symptomatic gallstones should undergo cholecystectomy unless there is a major medical contraindication. Asymptomatic pts are better off waiting for the development of sx than having prophylactic surgery. Those with acute cholecystitis should undergo surgery promptly after resuscitation because up to 20% will have gangrene or perforation, and a delayed operation results in higher complication rates (BMJ 2002;325:639). The laparoscopic approach has replaced open cholecystectomy without a randomized trial to support its use. Shortened hospital stays, reduced pain, shorter recovery time, and consumer demand have dictated that an RCT will never be done. Expected mortality of lap chole is 0.1-0.2%, and complications occur in 5%. These rates are similar to the rates for the open operation (Ann Surg 1993;218:129). Contraindications to the laparoscopic approach include scarring or inflammation that prevents access to the RUQ, diffuse peritonitis, and coagulopathy. The laparoscopic approach cannot be used for all pts, and some pts (less than 5%) must be converted to the open operation. Though indications for lap chole are supposedly no different than for open chole, the advent of the laparoscopic approach has increased utilization by about 11% (Surg Endosc 1996;10:746).


  • Lap chole and the common bile duct: Access to the bile duct is notas easy with lap chole as with open chole. About 8-17% of pts who undergo cholecystectomy are diagnosed with common bile duct stones (CBDS), and 1-2% will have retained stones diagnosed after surgery (J Am Coll Surg 1998;187:584). A great deal of effort has been put into methods of predicting the presence of common duct stones based on noninvasive data such as LFTs and US findings. About 90% of pts are considered low risk for CBDS because they have normal LFTs, no bile duct dilatation, and no hx of jaundice or pancreatitis. Even in this low-risk group, the incidence of stones is up to 5%. An algorithm for management of suspected common duct stones is available (Gastro Endosc 2010;71:1). When there is a high probability of stones (bilirubin >4 mg/dl, CBD stone on US, cholangitis, or dilated CBD on US with bilirubin 1.8-4 mg/dl) ERCP is performed prior to lap chole. When there is an intermediate probability of stones (abnormal LFTs, gallstone pancreatitis, dilated CBD on US, or age 55 and none of the high probability findings just discussed) then intraoperative cholangiogram, MRCP or EUS are considerations. Pts with positive cholangiograms undergo (1) postoperative ERCP with sphincterotomy and stone extraction, (2) laparoscopic removal of common duct stones (in the hands of experts) (World J Surg 1998;22:1125), or rarely (3) conversion to an open operation. Laparoscopic methods to explore the bile duct have fewer complications and cost less if done at expert centers, but those outcomes are notlikely in the typical community (Am Surg 1999;65:135). Local expertise usually dictates the approach.


  • Complications of cholecystectomy: The most feared complication of lap chole is bile duct injury. Bile duct injuries can be (1) major transections or ligations of the ducts, (2) leaks from the cystic duct stump, or (3) leaks from superficial branches of the right hepatic
    ducts that are exposed at surgery (Am J Surg 1994;167:27). Biliary injuries occur more often in the hands of inexperienced surgeons (Brit J Surg 1995;82:307) and in acute cholecystitis (Arch Surg 1996;131:382). Pts with bile duct injuries present with pain and, to varying degrees, abdominal distention, ileus, and fever. LFTs may be normal or near normal in pts with leaks, but jaundice develops if the duct has been ligated. When a leak is suspected, HIDA scan usually demonstrates the leak and imaging studies may show a fluid collection. Leaks of the cystic duct stump or branches of the right hepatic system can be treated by placing a stent across the sphincter of Oddi at ERCP (Gastrointest Endosc 1993;39:416). As long as the stent crosses the sphincter and reduces pressure in the bile duct, the leak is sealed in the vast majority of cases (Am J Gastro 1995;90:2128). The stent is removed several weeks later, and closure of the leak is verified. Some experts prefer to do a sphincterotomy and place a nasobiliary tube. The nasobiliary tube usually can be removed in a few days when the edema of the sphincterotomy subsides, and the pt is spared a second procedure. No direct comparative studies are available. Major transections may require operative intervention and are associated with a high incidence of subsequent stricture, high cost, and mortality (Ann Surg 1997;225:268). Other notable complications are bleeding and bowel injury (Nejm 1991;324:1073). Stones may be lost into the abdomen and infrequently result in infectious or mechanical complications (Surg Endosc 1999;13:848).

    Only gold members can continue reading. Log In or Register to continue

    Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in GASTROENTEROLOGY | Comments Off on The Biliary Tree

Full access? Get Clinical Tree

Get Clinical Tree app for offline access